iohexol has been researched along with paclitaxel in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Böhm, M; Clauss, W; Scheller, B; Schmitt, A; Sovak, M; Speck, U; Stoll, HP | 1 |
| Böhm, M; Romeike, B; Scheller, B; Schmitt, A; Sovak, M; Speck, U; Stoll, HP | 1 |
| Böhm, M; Nickenig, G; Scheller, B; Schmitt, A; Speck, U | 1 |
| Abramjuk, C; Bernhardt, U; Scheller, B; Speck, U | 1 |
| Kiessling, F; Kobayashi, M; Koike, K; Richter, GM; Semmler, W; Stampfl, U; Stiller, W | 1 |
| Aboodi, MS; Conditt, GB; Granada, JF; Gray, WA; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A; Thim, T; Virmani, R; Yi, GH | 1 |
| Bayer, G; Byrne, RA; Hartwig, S; Joner, M; Joost, A; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
| Böhm, M; Clever, YP; Cremers, B; Krauss, B; Laufs, U; Scheller, B; Speck, U | 1 |
| Borges, AC; Bräutigam, M; Clever, Y; Cremers, B; Dietz, U; Richter, W; Rutsch, W; Scheller, B; Speck, U | 1 |
| Afari, M; Buszman, PP; Cheng, Y; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A | 1 |
| Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A | 1 |
| Betala, JV; LaBerge, M; Langan Iii, EM | 1 |
| Lansky, AJ; Mena, C; Ng, VG; Pietras, C | 1 |
| Grabow, N; Kaule, S; Kempin, W; Nagel, S; Petersen, S; Reske, T; Schmitz, KP; Seidlitz, A; Weitschies, W | 1 |
| An, X; Du, R; Han, H; Ni, J; Ying, C; Zhang, J; Zhang, R; Zhu, J; Zhu, Z | 1 |
| Atigh, MK; Christians, U; Erwin, MM; Turner, EA; Yazdani, SK | 1 |
| Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F | 1 |
| McDermott, MK; NguyenPho, A; Oktem, B; Tran, M; Wickramasekara, S; Woolford, SE | 1 |
| Beumer, JH; Christner, S; Chu, E; Guo, J; Holleran, JL; Ivy, SP; Joshi, A; Kiesel, B; Miller, BM; Parise, RA; Taylor, S; Venkataramanan, R | 1 |
| Ding, F; Ge, J; He, Y; Hu, J; Ji, Z; Li, Y; Liu, L; Liu, X; Pang, W; Su, X; Tang, L; Yang, Z; Zhang, R; Zhou, G; Zhou, Y; Zhu, J; Zhu, Z | 1 |
| Burgmans, MC; Chan, ES; Chan, SXJM; Chng, SP; Chong, TT; Damodharan, K; Gogna, A; Irani, FG; Kwan, J; Leong, S; Patel, A; Pua, U; Quek, LHH; Tan, BP; Tan, BS; Tan, GWL; Tay, KH; Too, CW; Yuan, W; Zhuang, KD | 1 |
2 review(s) available for iohexol and paclitaxel
| Article | Year |
|---|---|
Drug-coated percutaneous balloon catheters.
Topics: Angioplasty, Balloon; Drug-Eluting Stents; Humans; Iohexol; Paclitaxel; Sirolimus; Vascular Access Devices | 2014 |
Local delivery of paclitaxel in the treatment of peripheral arterial disease.
Topics: Angioplasty, Balloon; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug-Eluting Stents; Glycerol; Humans; Infusions, Intravenous; Iohexol; Nanoparticles; Paclitaxel; Peripheral Arterial Disease; Pharmaceutical Vehicles; Tubulin Modulators | 2015 |
3 trial(s) available for iohexol and paclitaxel
| Article | Year |
|---|---|
Intracoronary local paclitaxel delivery by X-ray contrast media for in-stent restenosis: a clinical pilot study to assess safety and tolerability.
Topics: Aged; Algorithms; Cardiac Catheterization; Cardiovascular Agents; Contrast Media; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Female; Germany; Humans; Injections, Intra-Arterial; Iohexol; Male; Middle Aged; Paclitaxel; Pilot Projects; Recurrence; Stents; Treatment Outcome | 2012 |
A randomized comparison of a novel iopromide-based paclitaxel-coated balloon Shenqi versus SeQuent Please for the treatment of in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; China; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Drugs, Chinese Herbal; Female; Humans; Iohexol; Male; Middle Aged; Paclitaxel | 2021 |
Randomized Controlled Trial Comparing Drug-coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial.
Topics: Angiography; Angioplasty, Balloon; Contrast Media; Double-Blind Method; Drug Delivery Systems; Female; Humans; Iohexol; Ischemia; Limb Salvage; Lower Extremity; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Prospective Studies; Tubulin Modulators | 2021 |
20 other study(ies) available for iohexol and paclitaxel
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting.
Topics: Animals; Benzamides; Contrast Media; Coronary Angiography; Iodine; Iohexol; Ioxaglic Acid; Models, Animal; Paclitaxel; Prodrugs; Propanolamines; Stents; Swine; Taxoids | 2002 |
Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model.
Topics: Animals; Cell Division; Contrast Media; Coronary Restenosis; Drug Carriers; Feasibility Studies; Iohexol; Paclitaxel; Stents; Swine; Taxoids; Tunica Intima | 2003 |
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Contrast Media; Coronary Restenosis; Coronary Vessels; In Vitro Techniques; Iohexol; Paclitaxel; Stents; Swine | 2003 |
Drug delivery by angiographic contrast media: inhibition of restenosis.
Topics: Animals; Contrast Media; Coronary Angiography; Coronary Restenosis; Drug Carriers; Iodized Oil; Iohexol; Paclitaxel; Stents; Swine | 2005 |
Initial Experience with a Novel Low-Dose Micro-CT System.
Topics: Animals; Coated Materials, Biocompatible; Contrast Media; Coronary Angiography; Coronary Restenosis; Equipment Design; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iohexol; Iopamidol; Mice; Mice, Nude; Miniaturization; Muscle, Skeletal; Neoplasm Transplantation; Paclitaxel; Phantoms, Imaging; Radiation Dosage; Rats; Sensitivity and Specificity; Soft Tissue Neoplasms; Stents; Swine; Tomography Scanners, X-Ray Computed | 2007 |
Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
Topics: Angioplasty, Balloon; Animals; Blood Circulation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Femoral Artery; Iohexol; Metals; Models, Animal; Neointima; Paclitaxel; Pilot Projects; Radiography; Regional Blood Flow; Stents; Swine | 2011 |
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
Topics: Angioplasty, Balloon, Coronary; Animals; Butyrates; Cardiovascular Agents; Citrates; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Equipment Design; Excipients; Female; Iohexol; Lecithins; Male; Models, Animal; Paclitaxel; Sus scrofa; Time Factors; Wound Healing | 2011 |
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Topics: Angioplasty, Balloon, Coronary; Animals; Apoptosis; Cardiovascular Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug-Eluting Stents; Endothelial Cells; Equipment Design; Humans; Iohexol; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paclitaxel; Sirolimus; Stem Cells; Sus scrofa; Time Factors | 2011 |
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Constriction, Pathologic; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Iohexol; Neointima; Paclitaxel; Polymers; Swine | 2013 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Contrast Media; Disease Models, Animal; Equipment Design; Femoral Artery; Fibrosis; Hyperlipoproteinemia Type II; Iliac Artery; Iohexol; Neointima; Paclitaxel; Radiography; Sus scrofa; Tissue Distribution; Vascular Access Devices; Wound Healing | 2013 |
In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons.
Topics: Abattoirs; Absorption, Physiological; Adhesiveness; Adsorption; Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Animals; Carotid Arteries; Contrast Media; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Excipients; In Vitro Techniques; Iohexol; Paclitaxel; Perfusion; Povidone; Solvents; Surface Properties; Sus scrofa | 2015 |
Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis.
Topics: Animals; Aorta, Abdominal; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Iohexol; Paclitaxel; Rabbits; Treatment Outcome; Tubulin Modulators; Vascular Access Devices | 2015 |
Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
Topics: Angioplasty, Balloon; Animals; Bioreactors; Cardiovascular Agents; Carotid Arteries; Coated Materials, Biocompatible; Drug Liberation; Excipients; Iohexol; Materials Testing; Paclitaxel; Serum Albumin, Bovine; Surface Properties; Sus scrofa; Tissue Culture Techniques; Tissue Distribution; Urea; Vascular Access Devices | 2018 |
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method.
Topics: Angioplasty, Balloon, Coronary; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Excipients; Iohexol; Microscopy, Electron, Scanning; Paclitaxel; Reproducibility of Results; Technology, Pharmaceutical | 2019 |
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker.
Topics: Administration, Intravenous; Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow; Carboplatin; Contrast Media; Creatinine; Cytochrome P-450 Enzyme System; Deoxycytidine; Drug Dosage Calculations; Drug Interactions; Female; Gemcitabine; Glomerular Filtration Rate; Glucuronosyltransferase; Humans; Iohexol; Kidney; Metabolic Clearance Rate; Mice; Microsomes, Liver; Models, Animal; Paclitaxel; Specific Pathogen-Free Organisms; Tandem Mass Spectrometry; Tissue Distribution | 2020 |